Open access
Open access
Powered by Google Translator Translator

Study shows Omicron sublineage BQ.1.1 is resistant to all monoclonal antibodies.

29 Nov, 2022 | 14:16h | UTC

Omicron sublineage BQ.1.1 resistance to monoclonal antibodies – The Lancet Infectious Diseases

Commentaries: 

New Omicron subvariant BQ.1.1 resistant to all therapeutic antibodies, study finds – Deutsches Primatenzentrum (DPZ)/German Primate Center

Omicron variant BQ.1.1 found to be resistant to all monoclonal antibody treatments – MedicalXpress

Related: BQ.1 and BQ.1.1 are now the dominant COVID variants. What does that mean? – MedicalXpress

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.